Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

Share Price is delayed by 15 minutes
Get Live Data
50.55    0.00 (0.00%)
Bid:
49.60
Ask:
51.50
Spread: 1.90 (3.831%)
Market Cap: £193.32m
BSC Live PriceLast checked at - London Stock Exchange

Intraday Br.small Co.2 Share Chart

Interim Management Statement

16 Nov 2009 13:19

RNS Number : 5697C
British SmallerTechCompaniesVCT2PLC
16 November 2009
 



BRITISH SMALLER TECHNOLOGY COMPANIES VCT 2 PLC ("the Company")

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2009

British Smaller Technology Companies VCT 2 plc presents its interim management statement for the quarter ended 30 September 2009. This constitutes the Company's second interim management statement for the financial year ending 31 December 2009, as required by Rule 4.3 of the Disclosure and Transparency Rules. A copy of this interim management statement can be found at www.yfmgroup.co.uk.

The unaudited net asset value per Ordinary share as at 30 September 2009 was 73.0p (30 June 200975.7p). The net asset value as at 30 September 2009 is stated after taking account of the interim dividend of 2.0p per Ordinary share and the special dividend of 2.0p per Ordinary share in respect of the year ended 31 December 2009. These dividends were paid on 2 October 2009 and 30 October 2009 respectively.

The total return at 30 September 2009, calculated by reference to the net asset value per share and the cumulative dividends paid and proposed, increased to 95.0p per share from 93.7p at 30 June 2009.

The number of Ordinary shares in issue at 30 September 2009 was 16,641,257. There were no shares purchased or issued by the Company during the quarter.

Net assets at 30 September 2009 comprised the following:

£000

% of net assets

Unquoted investments at fair value

4,677

38.5%

Quoted investments at bid price

1,023

8.4%

Gilt investments

3,898

32.1%

Total investments

9,598

79.0%

Cash and cash equivalents

1,986

16.3%

Other net current assets (liabilities)

570

4.7%

Net assets

12,154

100.0%

The ten largest investments by valuation at 30 September 2009 were as follows:

£000

% of net assets

Digital Healthcare Limited

1,659

13.6%

Immunobiology Limited

807

6.6%

Primal Pictures Limited

742

6.1%

Pressure Technologies plc

440

3.6%

Silistix Limited

387

3.2%

Waterfall Services Limited

382

3.2%

Harvey Jones Limited

273

2.3%

Patsystems plc

258

2.1%

Ellfin Home Care Limited

150

1.2%

RMS Group Holdings Limited

146

1.2%

Top ten investments

5,244

43.1%

Other investments

456

3.8%

Gilt investments

3,898

32.1%

Total investments

9,598

79.0%

Quoted investments are carried at bid price at 30 September 2009. Unquoted investment are carried at fair value as at 30 September 2009 as determined by the directors.

During the three months ended 30 September 2009 the following significant investment transactions took place (all companies are unquoted except where otherwise indicated):

Disposals

Name of company:

Sale proceeds

£000

Original 

cost

£000

Carrying value at 

30 June 2009

£000

DxS 

1,755*

163

817

ART Technology Group (AiM)

567

244

519

Oxonica (AiM)

3

62

6

RMS Group Holdings 

3

3

3

2,328

472

1,345

* excluding deferred proceeds of £214,000

Performance 

In this period the Company has seen its underlying net asset value decrease by 2.7p per share after the payment of an interim dividend of 2.0p per Ordinary share and a special dividend of 2.0p per Ordinary share. 

The total return, calculated by reference to the net asset value plus cumulative dividend paid and proposed has increased by 1.3p to 95.0p per share, cumulative dividends representing 22.0p per share.

The net asset value currently comprises 48% in cash and gilts and as such the Company is well placed to take advantage of selective investment opportunities as they arise.

The net asset value per share remains significantly in excess of the current share price.

Outlook 

Whilst there remains uncertainty over the speed of recovery in the markets the last quarter has demonstrated that positive realisations are still possible for the right quality of investments. There is some evidence of an increasing search for capital from businesses seeking to expand which your Board believes will translate into increasing investment opportunities over both the short and medium term. This Company is well placed to continue to support these investments and take advantage of investment opportunities that may arise in the short term and is intending to ensure it has sufficient capacity to meet future investment demand. 

16 November 2009

For further information please contact:

David Hall  YFM Private Equity Tel: 0161 832 7603

Jeff Keating Singer Capital Markets Tel: 0203 205 7500

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGUGMGGUPBGWQ
Date   Source Headline
23rd Aug 20176:00 pmRNSHalf-year Report
26th Jun 201710:58 amRNSTransaction in Own Shares
12th May 201710:11 amRNSPayment of Final Dividend and Allotment of Shares
10th May 20172:57 pmRNSAGM Statement
10th May 20179:51 amRNSInterim Management Statement
13th Apr 20171:47 pmRNSTransaction in Own Shares
21st Mar 20171:25 pmRNSAnnual Financial Report
10th Feb 201710:47 amRNSIssue of Equity and Close of Offer
30th Jan 20172:07 pmRNSOffer for Subscription
10th Jan 201710:25 amRNSClose of Offer to new Subscriptions
3rd Jan 201711:59 amRNSOffer for Subscription
6th Dec 201610:06 amRNSChange of Stockbrokers
29th Nov 20169:46 amRNSPurchase of own securities and total voting rights
22nd Nov 20163:30 pmRNSInterim Management Statement
26th Sep 201610:30 amRNSPayment of Interim Dividend and Share Allotment
22nd Aug 201611:01 amRNSChange of auditor
11th Aug 20162:06 pmRNSHalf-year Report
8th Jul 201611:32 amRNSCompletion of new investment
15th Jun 20163:25 pmRNSTransaction in Own Shares
9th May 20169:53 amRNSPayment of Final Dividend and Allotment of Shares
6th May 20162:25 pmRNSResult of Annual General Meeting
6th May 201610:05 amRNSInterim Management Statement
27th Apr 20164:55 pmRNSPurchase of Own Securities and Total Voting Rights
24th Mar 20164:46 pmRNSTransaction in Own Shares
24th Mar 20162:58 pmRNSAnnual Financial Report
25th Feb 20163:13 pmRNSDisclosure of Home Member State
14th Jan 20162:23 pmRNSIssue of Equity and Close of Offer
23rd Dec 201510:21 amRNSClose of Offer to New Subscriptions
8th Dec 20152:10 pmRNSOffer for Subscription
23rd Nov 201512:24 pmRNSInterim Management Statement
28th Sep 201510:18 amRNSPayment of Interim Dividend and Allotment of Share
14th Aug 20152:18 pmRNSHalf Yearly Report
23rd Jun 20151:04 pmRNSTransaction in Own Shares
8th Jun 201510:08 amRNSIssue of Equity
18th May 20155:41 pmRNSResult of Annual General Meeting
15th May 201511:00 amRNSInterim Management Statement
6th May 20151:33 pmRNSPurchase of Own Securities and Total Voting Rights
22nd Apr 20152:01 pmRNSIssue of Equity and Close of Offers
10th Apr 20153:38 pmRNSOffers for Subscription - Supplementary Prospectus
31st Mar 20154:40 pmRNSCompletion of new investment
31st Mar 201511:53 amRNSIssue of Equity Replacement
31st Mar 20157:00 amRNSIssue of Equity
27th Mar 20157:00 amRNSAnnual Financial Report
24th Mar 20159:46 amRNSClose of Offers to New Applications
9th Mar 20154:24 pmRNSOver Allotment Facility
2nd Mar 20154:33 pmRNSIssue of Equity
3rd Feb 20157:00 amRNSIssue of Equity
6th Jan 20153:34 pmRNSIssue of Equity
31st Dec 20141:00 pmRNSTotal Voting Rights at 31 December 2014
22nd Dec 20143:15 pmRNSRealisation of Investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.